We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Continuous Glucose Sensor Aids Diabetics

By HospiMedica staff writers
Posted on 07 Apr 2006
A medical device that continuously monitors glucose will greatly improve the quality of diabetes care and lower the risk of complications such as loss of sight, heart attacks, kidney failure, and amputation. More...
It is an important step toward the development of an artificial pancreas for people suffering from diabetes.

The Juvenile Diabetes Research Foundation (JDRF, New York, NY, USA), a charitable supporter of research on type 1 diabetes, has announced that a new device, the Short Term Sensor (STS) continuous glucose monitoring system, has been approved by the U.S. Food and Drug Administration (FDA). Developed by DexCom Inc., (San Diego, CA, USA), the monitoring system is a patient-insertable short-term sensor that wirelessly transmits blood-glucose readings to a handheld receiver.

The wire-like sensor is inserted via an applicator by the user or clinician just under the skin and held in place by an adhesive to the skin. Once inserted, the user wears the sensor for up to three days when the patient removes and discards it. A new sensor is then used with the same receiver. The STS receiver provides continuous glucose values, one-, three-, and nine-hour glucose trend information, high- and low-glucose alerts, and low-glucose alarm. The patient is able to adjust medication, diet, and exercise according to the glucose levels.

Monitors such as these are the keys to the development of a closed-loop glucose testing and insulin delivery system, or an "artificial pancreas.” Closed loop technology will provide patients with far more information about their daily glucose fluctuations and trends and allow for far-tighter control. Patients who aggressively manage their diabetes typically test their glucose levels up to eight times a day, and provide insulin injections based on that information. The artificial pancreas will test the glucose approximately 1,400 times a day, and make insulin available based on real-time information.

"The development of an artificial pancreas has been one of JDRF's top research goals, and we are cautiously optimistic that these new products will be as successful and beneficial to people with diabetes as we hope,” said Aaron Kowalski, Ph.D., Director of research projects at JDRF.



Related Links:
JDRF
DexCom

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Cardiograph Device
PageWriter TC35
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.